JP2014505679A5 - - Google Patents

Download PDF

Info

Publication number
JP2014505679A5
JP2014505679A5 JP2013546228A JP2013546228A JP2014505679A5 JP 2014505679 A5 JP2014505679 A5 JP 2014505679A5 JP 2013546228 A JP2013546228 A JP 2013546228A JP 2013546228 A JP2013546228 A JP 2013546228A JP 2014505679 A5 JP2014505679 A5 JP 2014505679A5
Authority
JP
Japan
Prior art keywords
animal
dgla
composition
probiotics
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013546228A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014505679A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/065173 external-priority patent/WO2012087745A1/en
Publication of JP2014505679A publication Critical patent/JP2014505679A/ja
Publication of JP2014505679A5 publication Critical patent/JP2014505679A5/ja
Pending legal-status Critical Current

Links

JP2013546228A 2010-12-21 2011-12-15 変形性関節症の予防及び治療のための方法及び組成物 Pending JP2014505679A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061459902P 2010-12-21 2010-12-21
US61/459,902 2010-12-21
PCT/US2011/065173 WO2012087745A1 (en) 2010-12-21 2011-12-15 Methods and compositions for preventing and treating osteoarthritis

Publications (2)

Publication Number Publication Date
JP2014505679A JP2014505679A (ja) 2014-03-06
JP2014505679A5 true JP2014505679A5 (enExample) 2015-01-29

Family

ID=46314373

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013546228A Pending JP2014505679A (ja) 2010-12-21 2011-12-15 変形性関節症の予防及び治療のための方法及び組成物

Country Status (11)

Country Link
US (1) US20140205569A1 (enExample)
EP (1) EP2654744A4 (enExample)
JP (1) JP2014505679A (enExample)
CN (1) CN103384521A (enExample)
AU (1) AU2011349718B2 (enExample)
BR (1) BR112013018453A2 (enExample)
CA (1) CA2822263A1 (enExample)
MX (1) MX2013007191A (enExample)
RU (1) RU2013133998A (enExample)
WO (1) WO2012087745A1 (enExample)
ZA (1) ZA201305497B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
WO2014022816A2 (en) * 2012-08-03 2014-02-06 Dignity Sciences Limited Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same
WO2015185698A1 (en) 2014-06-04 2015-12-10 Dignity Sciences Limited Pharmaceutical compositions comprising dgla and use of same
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
US6765020B2 (en) * 1995-08-07 2004-07-20 Suntory Limited Drugs for prevention and treatment of diseases caused by abnormalities in cartilage tissues
GB9622636D0 (en) * 1996-10-30 1997-01-08 Scotia Holdings Plc Presentation of bioactives
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
JP4343477B2 (ja) * 2000-05-25 2009-10-14 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ペットフード用新規プロバイオチックス
US20020188024A1 (en) * 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
AU2004266601B2 (en) * 2003-08-11 2011-03-24 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for the treatment of canine ostheoarthritis
ES2998457T3 (en) * 2003-11-21 2025-02-20 Nestle Sa Food composition comprising glucosamine
AU2005259386B2 (en) * 2004-07-01 2011-11-03 Société des Produits Nestlé S.A. Canine osteoarthritis diet formulation
EP1852114B1 (en) * 2005-02-14 2019-09-18 Suntory Holdings Limited Composition containing dihomo-y-linolenic acid (dgla) as active ingredient
CN101460185A (zh) * 2006-04-03 2009-06-17 雀巢产品技术援助有限公司 用于促进骨生长和维持骨健康的营养组合物及与其有关的方法

Similar Documents

Publication Publication Date Title
IN2012DN00760A (enExample)
MY153062A (en) Methods of treating gastrointestinal disorders independent of the intake of food
RU2012114786A (ru) Питательные композиции, содержащие экзогенный витамин к2
MX2009009318A (es) Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
WO2011014255A8 (en) Treatment of crohn's disease with laquinimod
WO2018084531A3 (ko) 골 질환, 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
JP2014505679A5 (enExample)
JP2015523321A5 (enExample)
PH12014502447A1 (en) Use of high dose laquinimod for treating multiple sclerosis
WO2013166177A3 (en) Pterostilbene and curcumin combination for treatment of oxidative stress and inflammation
EA201000854A1 (ru) Применение эдта и ее солей для профилактики и лечения дизентерии свиней и усиления эффектов антибиотиков, проявляющихся при этом заболевании
WO2011002298A3 (en) Animal feed or human food for improving intestinal barrier properties
EA201100154A1 (ru) Способ лечения заболеваний толстой кишки
WO2008071790A3 (en) Novel compositions and uses thereof
RU2013133998A (ru) Способы и композиции для предотвращения и лечения остеоартрита
RU2017122615A (ru) Применение пробиотиков для усиления мужской фертильности
EP2575456A4 (en) COMPOSITIONS AND METHODS FOR TREATING PRESENTATIONS
JP2017061488A5 (enExample)
RU2008126860A (ru) Способ повышения продуктивности и качества продукции овцеводства
RU2013154564A (ru) Способы и композиции для стимуляции роста безжировой массы тела
MX2013006353A (es) Metodos y composiciones utiles para promover el sueño en animales.
WO2011133681A3 (en) Low/high dose probiotic supplements and methods of their use
WO2016008642A3 (en) Compositions comprising cinnamaldehyde and zinc and methods of using such compositions
UA94975C2 (ru) Композиция и ее применение для лечения гипергликемии и связанных с ней болезней
NZ613264A (en) Use of vitamin k for weight maintenance and weight control